3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
23 23 0 0 0 0 0 0 0999 V2000
3.2122 -1.4485 0.2688 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.4157 1.5811 0.8464 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.7353 -1.0542 -0.0709 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3984 1.3907 -1.4713 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6851 0.5952 -0.1484 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3834 -1.4042 0.0519 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0027 1.0609 -0.1226 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8713 -0.5106 0.0033 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6064 -0.3727 -0.0843 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5170 -1.7067 0.2362 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9390 0.2196 -0.0276 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1938 0.9888 -0.3429 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9825 2.8919 0.7719 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5118 -2.2314 0.0896 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0992 -2.6924 0.3857 H 0 0 0 0 0 0 0 0 0 0 0 0
3.8850 2.0536 -0.2968 H 0 0 0 0 0 0 0 0 0 0 0 0
4.9567 0.7299 -0.0229 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.1146 3.2643 1.7912 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9604 2.8548 0.2821 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.3080 3.5667 0.2361 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.5679 -1.9654 -0.0051 H 1 0 0 0 0 0 0 0 0 0 0 0
-3.3460 -2.6644 1.0810 H 1 0 0 0 0 0 0 0 0 0 0 0
-3.2621 -2.9609 -0.6871 H 1 0 0 0 0 0 0 0 0 0 0 0
1 10 1 0 0 0 0
1 11 1 0 0 0 0
2 12 1 0 0 0 0
2 13 1 0 0 0 0
3 6 1 0 0 0 0
3 14 1 0 0 0 0
4 12 2 0 0 0 0
5 8 1 0 0 0 0
5 11 2 0 0 0 0
6 9 2 0 0 0 0
7 11 1 0 0 0 0
7 16 1 0 0 0 0
7 17 1 0 0 0 0
8 9 1 0 0 0 0
8 10 2 0 0 0 0
9 12 1 0 0 0 0
10 15 1 0 0 0 0
13 18 1 0 0 0 0
13 19 1 0 0 0 0
13 20 1 0 0 0 0
14 21 1 0 0 0 0
14 22 1 0 0 0 0
14 23 1 0 0 0 0
M ISO 3 21 2 22 2 23 2
4. 国际命名与标识
4.1 IUPAC Name
methyl (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(trideuteriomethoxyimino)acetate
4.2 InChl
InChI=1S/C7H9N3O3S/c1-12-6(11)5(10-13-2)4-3-14-7(8)9-4/h3H,1-2H3,(H2,8,9)/b10-5-/i2D3
4.3 InChlKey
MJAIDGPTIFCPGD-FAVSQNOZSA-N
4.4 Canonical SMILES
COC(=O)C(=NOC)C1=CSC(=N1)N
4.5 lsomeric SMILES
[2H]C([2H])([2H])O/N=C(/C1=CSC(=N1)N)\C(=O)OC
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病